Organon & Co.
OGN
$8.04
-$0.40-4.74%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 750.00M | 864.00M | 1.30B | 1.00B | 1.05B |
Total Depreciation and Amortization | 296.00M | 277.00M | 260.00M | 252.00M | 244.00M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 72.00M | 76.00M | -450.00M | -278.00M | -315.00M |
Change in Net Operating Assets | -180.00M | -278.00M | -165.00M | 92.00M | -215.00M |
Cash from Operations | 938.00M | 939.00M | 946.00M | 1.07B | 761.00M |
Capital Expenditure | -161.00M | -175.00M | -199.00M | -212.00M | -251.00M |
Sale of Property, Plant, and Equipment | 4.00M | 4.00M | 2.00M | 1.00M | 1.00M |
Cash Acquisitions | -241.00M | -166.00M | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -191.00M | -176.00M | -101.00M | -67.00M | -52.00M |
Cash from Investing | -589.00M | -513.00M | -298.00M | -278.00M | -302.00M |
Total Debt Issued | 1.28B | 1.19B | 1.04B | 1.04B | 80.00M |
Total Debt Repaid | -1.29B | -1.20B | -1.05B | -1.05B | -88.00M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -21.00M | -22.00M | -20.00M | -20.00M | -18.00M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -298.00M | -297.00M | -296.00M | -296.00M | -291.00M |
Other Financing Activities | -38.00M | -38.00M | -36.00M | -36.00M | -- |
Cash from Financing | -369.00M | -368.00M | -363.00M | -363.00M | -317.00M |
Foreign Exchange rate Adjustments | -8.00M | -76.00M | 64.00M | -47.00M | -26.00M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -28.00M | -18.00M | 349.00M | 378.00M | 116.00M |